Cargando…
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States
SARS-CoV-2 was identified and diagnostic methods developed at an impressive speed due in great part to the wider use of molecular methods in 2019 compared with 2002 during the SARS pandemic. The development of rapid and novel molecular diagnostic assays, leveraging of the high adaptability of molecu...
Autores principales: | Dien Bard, Jennifer, Babady, N. Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901381/ https://www.ncbi.nlm.nih.gov/pubmed/35636819 http://dx.doi.org/10.1016/j.cll.2022.02.007 |
Ejemplares similares
-
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
por: Truong, Thao T., et al.
Publicado: (2022) -
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations
por: Shen, Lishuang, et al.
Publicado: (2021) -
Early pandemic molecular diversity of SARS-CoV-2 in children
por: Moustafa, Ahmed M., et al.
Publicado: (2021) -
Comprehensive Genome Analysis of 6,000 USA SARS-CoV-2 Isolates Reveals Haplotype Signatures and Localized Transmission Patterns by State and by Country
por: Shen, Lishuang, et al.
Publicado: (2020) -
Evaluation of sample pooling for SARS-CoV-2 RNA detection in nasopharyngeal swabs and salivas on the Roche Cobas 6800
por: McMillen, Tracy, et al.
Publicado: (2021)